PULSE BIOSCIENCES, INC.

PLSE Nasdaq CIK: 0001625101

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 3957 POINT EDEN WAY, HAYWARD, CA, 94545
Mailing Address 3957 POINT EDEN WAY, HAYWARD, CA, 94545
Phone 510-906-4600
Fiscal Year End 1231
EIN 465696597

Financial Overview

FY2025

$114.86M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events March 27, 2026 View on SEC
8-K Current report of material events March 17, 2026 View on SEC
8-K Current report of material events March 12, 2026 View on SEC
8-K Current report of material events March 9, 2026 View on SEC
8-K Current report of material events March 3, 2026 View on SEC
8-K/A Current report amendment March 2, 2026 View on SEC
8-K Current report of material events February 27, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC
424B5 Prospectus supplement February 19, 2026 View on SEC
8-K Current report of material events February 19, 2026 View on SEC

Annual Reports

10-K February 19, 2026
  • PULSE BIOSCIENCES is transitioning from an R&D-centric model to active commercialization of its proprietary Nano-pulse Stimulation (NPS) technology.
  • The company significantly increased investment in R&D, SG&A, and G&A in 2025, signaling a strong commitment to product development and market entry.
View Analysis

Material Events

8-K Strategy Change March 17, 2026
High Impact
  • Pulse Biosciences is making a bold strategic pivot to its nPulse Cardiac Catheter System for AFib, a market estimated at over $7 billion annually.
  • The nPulse System showed highly promising clinical data: 90% acute procedural success and 75% freedom from AFib recurrence at 12 months with no device-related serious adverse events.
View Analysis

Insider Trading

STRONG SELL 1 insiders 7 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.